119
Participants
Start Date
February 5, 2018
Primary Completion Date
November 12, 2019
Study Completion Date
November 12, 2019
TEV-50717
6, 9, 12, 15, and 18 mg oral tablets
Placebo
Placebo matched to TEV-50717 tablets will be taken BID for 12 weeks.
Teva Investigational Site 046-0302, Herlev
Teva Investigational Site 046-0301, Odense
Teva Investigational Site 046-0124, New York
Teva Investigational Site 046-1702, Belgrade
Teva Investigational Site 046-1703, Belgrade
Teva Investigational Site 046-0102, Rochester
Teva Investigational Site 046-0112, Rochester
Teva Investigational Site 046-1701, Novi Sad
Teva Investigational Site 046-0118, Petersburg
Teva Investigational Site 046-0125, Raleigh
Teva Investigational Site 046-0605, Madrid
Teva Investigational Site 046-0602, Madrid
Teva Investigational Site 046-0603, Málaga
Teva Investigational Site 046-0116, Atlanta
Teva Investigational Site 046-0115, Orlando
Teva Investigational Site 046-0132, Miami
Teva Investigational Site 046-0114, St. Petersburg
Teva Investigational Site 046-0104, Dothan
Teva Investigational Site 046-0601, Seville
Teva Investigational Site 046-0133, Naperville
Teva Investigational Site 046-0110, Saint Charles
Teva Investigational Site 046-0107, Rogers
Teva Investigational Site 046-0106, Oklahoma City
Teva Investigational Site 046-0113, Dallas
Teva Investigational Site 046-0108, Houston
Teva Investigational Site 046-0103, Houston
Teva Investigational Site 046-0120, San Antonio
Teva Investigational Site 046-0105, Orem
Teva Investigational Site 046-0117, Sun City
Teva Investigational Site 046-0111, San Diego
Teva Investigational Site 046-0130, Santa Ana
Teva Investigational Site 046-0126, Anaheim
Teva Investigational Site 046-0101, Sacramento
Teva Investigational Site 046-0702, Stavropol
Teva Investigational Site 046-0703, Voronezh
Teva Investigational Site 046-0704, Tomsk
Teva Investigational Site 046-0128, Boston
Teva Investigational Site 046-0134, Lincoln
Teva Investigational Site 046-0109, Voorhees Township
Teva Investigational Site 046-0201, Ajax
Teva Investigational Site 046-0202, Ottawa
Teva Investigational Site 046-0604, Barcelona
Collaborators (1)
Nuvelution TS Pharma, Inc.
INDUSTRY
Teva Branded Pharmaceutical Products R&D, Inc.
INDUSTRY